Matching slides 110,355
Current window 74,881-74,910
Pages 3,679
Rows per page 30
Component: Source Noteclear collectionreset all

Component

74,881-74,910 of 110,355

filter-aware
18
Includes a highlight box around the primary performance metrics for CRC and AA.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
19
The slide uses two scatter plots to compare diagnostic performance metrics against competitors like Guardant Health, CellMax Life, and Cologuard.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations Beat · Market Size1 hit
26
Includes income statement items, balance sheet data, and equity structure.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
16
The slide highlights both the clinical urgency and the commercial orphan disease opportunity.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
19
Uses a combination of an equation-style value proposition and a chevron-based process/timeline diagram.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
21
The slide uses a matrix-like structure to map disease areas (Infection, Inflammation, Oncology) to specific animal models and clinical indications.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
23
The chart demonstrates high uptake efficiency of LNC-formulated oligos over time across different cell types.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
27
Uses a chevron-based process flow to represent maturity stages.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Why Now1 hit
09
Includes a map showing shipping routes between Tacoma and Alaskan ports.Matson | Investor Presentation Deck | 14 slides · Matson
Pitch deck Investor relations 1 hit
11
The chart shows equity income from 2018 to 2022, with a small LTM 3Q23 bar.Matson | Investor Presentation Deck | 14 slides · Matson
Pitch deck Investor relations 1 hit
14
Includes detailed footnotes explaining adjustments for tax benefits/expenses and calculation methodologies.Matson | Investor Presentation Deck | 14 slides · Matson
Pitch deck Investor relations 1 hit
03
The slide uses a three-column layout to summarize key company pillars.MaxCyte | Results Presentation Deck | 25 slides · MaxCyte
Conference presentation Investor relations Beat · Problem1 hit
04
The slide uses a timeline framework to establish company history and credibility.MaxCyte | Results Presentation Deck | 25 slides · MaxCyte
Conference presentation Investor relations Beat · Problem1 hit
06
MaxCyte | Results Presentation Deck | 25 slidesMaxCyte | Results Presentation Deck | 25 slides · MaxCyte
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
The slide uses a process flow diagram to show the funnel of partnerships and clinical programs.MaxCyte | Results Presentation Deck | 25 slides · MaxCyte
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
The chart shows a cumulative growth curve of partner logos over time (2017-2023).MaxCyte | Results Presentation Deck | 25 slides · MaxCyte
Conference presentation Investor relations Beat · Market SizeLoop · Quick Win Big Bet1 hit
11
The slide uses donut charts to show the shift in milestone distribution across IND, Pre-Pivotal, and Pivotal or Later phases.MaxCyte | Results Presentation Deck | 25 slides · MaxCyte
Conference presentation Investor relations Beat · Market SizeLoop · Quick Win Big Bet1 hit
13
The slide uses a wave-based visual metaphor to represent sequential growth phases.MaxCyte | Results Presentation Deck | 25 slides · MaxCyte
Conference presentation Investor relations 1 hit
15
Includes Vitruvian Man illustration as a central visual anchor.MaxCyte | Results Presentation Deck | 25 slides · MaxCyte
Conference presentation Investor relations Loop · Voice Of Customer1 hit
08
Includes a leadership announcement at the bottom right.Membership Collective Group | Investor Presentation Deck | 31 slides · Soho House & Co Inc.
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
12
Includes footnotes regarding non-GAAP financial measures and expenses not added back for both periods.Membership Collective Group | Investor Presentation Deck | 31 slides · Soho House & Co Inc.
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
13
Includes a bar chart showing loan expiry profile by year and a list of Q3 2023 financial highlights.Membership Collective Group | Investor Presentation Deck | 31 slides · Soho House & Co Inc.
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
04
MindMed | Results Presentation Deck | 20 slidesMindMed | Results Presentation Deck | 20 slides · MindMed
Conference presentation Investor relations Beat · SetupLoop · Golden Circle1 hit
05
MindMed | Results Presentation Deck | 20 slidesMindMed | Results Presentation Deck | 20 slides · MindMed
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
06
The chart uses a horizontal bar format to represent progress through clinical phases (Pre-clinical to Phase 3).MindMed | Results Presentation Deck | 20 slides · MindMed
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
07
The slide uses a problem-solution framing, contrasting the large GAD patient population with the failure rates of existing therapies.MindMed | Results Presentation Deck | 20 slides · MindMed
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
08
MindMed | Results Presentation Deck | 20 slidesMindMed | Results Presentation Deck | 20 slides · MindMed
Conference presentation Investor relations Beat · Evidence & ProofLoop · Golden Circle1 hit
09
The slide uses a bar chart to show efficacy in a three-chamber social interaction test and an icon grid to summarize qualitative benefits.MindMed | Results Presentation Deck | 20 slides · MindMed
Conference presentation Investor relations Beat · Evidence & ProofLoop · Golden Circle1 hit
11
The slide uses a brain illustration to connect three key areas of focus for the drug.MindMed | Results Presentation Deck | 20 slides · MindMed
Conference presentation Investor relations Beat · Evidence & Proof1 hit
12
The slide uses a timeline-based clinical trial design diagram.MindMed | Results Presentation Deck | 20 slides · MindMed
Conference presentation Investor relations Beat · Evidence & Proof1 hit